The use of Mandibular Advancement Devices for Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea Syndrome (OSA) is a common disorder that is linked with increased morbidity and mortality. It is caused by an obstruction of the nasopharynx with the result of hypoxia. OSA is commonly treated by continuous positive airway pressure devices (CPAP). The use of Mandibular Advancement Devices (MADs), which increase the anteroposterior diameter of the throat thus making breathing easier and preventing the obstruction of the airway have also been used. Data for this paper were collected studying 12 patients with OSA. 10 out of 12 patients showed significant improvement in both the Apnea Hypopnea Index (AHI) and the symptomatology. Based on the literature, complications from the use of MADs are expected. Most of the patients reported increased sialorrhea for the first 2-3 days of treatment and temporary mucosal irritation. Despite minor complications experienced in some patients using the device, this study shows that the use of MADs is an easy, economical and effective way to treat individuals with OSA.